首页 > 最新文献

Biochemia Medica最新文献

英文 中文
Survey on reporting of epithelial cells in urine sediment as part of external quality assessment programs in Brazilian laboratories. 作为巴西实验室外部质量评估项目一部分的尿液沉积物上皮细胞报告调查。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 DOI: 10.11613/BM.2021.020711
José A T Poloni, Adriana de Oliveira Vieira, Caroline R M Dos Santos, Ana-Maria Simundic, Liane N Rotta

Introduction: Epithelial cells (ECs) are structures regularly observed during urine microscopy analysis. The correct identification of EC subtypes can be useful since renal tubular epithelial cells (RTECs) are clinically relevant. We investigate the urinary ECs report and the judgement of its clinical importance by Brazilian laboratories.

Materials and methods: A survey with four questions was made available to participants of the Urinalysis External Quality Assessment Program (EQAP) from Controllab. Laboratories composed 3 groups: (1) differentiating ECs subtypes: "squamous", "transitional" and "RTECs"; (2) differentiating ECs subtypes: "squamous" or "non-squamous" cells; (3) without ECs subtype identification. Participants did not necessarily answer to all questions and the answers were evaluated both within the same laboratory's category and within different categories of laboratories.

Results: A total of 1336 (94%) laboratories answered the survey; Group 1, 119/140 (85%) reported that ECs differentiation is important to the physician and 62% want to be evaluated by EQAP, while in Group 3, 455/1110 (41%) reported it is useful to them, however only 25% want be evaluated by EQAP. Group 2 laboratories 37/51 (73%) reported that the information is important, but only 13/52 (25%) are interested in an EQAP with differentiation of the 3 ECs subtypes.

Conclusion: Most of the laboratories do not differentiate ECs in the three subtypes, despite the clinical importance of RTECs. Education of laboratory staff about the clinical significance of urinary particles should be considered a key priority.

上皮细胞(ECs)是尿液显微镜分析中经常观察到的结构。由于肾小管上皮细胞(RTECs)与临床相关,因此正确识别EC亚型是有用的。我们调查尿ECs报告和巴西实验室对其临床重要性的判断。材料和方法:对Controllab尿液分析外部质量评估项目(EQAP)的参与者进行了一份包含四个问题的调查。实验室分为3个组:(1)不同的ec亚型:“鳞状”、“过渡性”和“rtec”;(2)分化内皮细胞亚型:“鳞状”或“非鳞状”细胞;(3)无ECs亚型鉴定。参与者不必回答所有问题,答案在同一实验室类别和不同实验室类别中进行评估。结果:共有1336家实验室(94%)参与调查;第1119 /140组(85%)报告ECs分化对医生很重要,62%的人希望通过EQAP进行评估,而第3455 /1110组(41%)报告ECs分化对他们有用,但只有25%的人希望通过EQAP进行评估。第2组有37/51(73%)的实验室报告信息很重要,但只有13/52(25%)的实验室对3种ECs亚型分化的EQAP感兴趣。结论:尽管rtec具有重要的临床意义,但大多数实验室并未区分三种亚型的ECs。对实验室工作人员进行有关尿颗粒临床意义的教育应被视为重中之重。
{"title":"Survey on reporting of epithelial cells in urine sediment as part of external quality assessment programs in Brazilian laboratories.","authors":"José A T Poloni,&nbsp;Adriana de Oliveira Vieira,&nbsp;Caroline R M Dos Santos,&nbsp;Ana-Maria Simundic,&nbsp;Liane N Rotta","doi":"10.11613/BM.2021.020711","DOIUrl":"https://doi.org/10.11613/BM.2021.020711","url":null,"abstract":"<p><strong>Introduction: </strong>Epithelial cells (ECs) are structures regularly observed during urine microscopy analysis. The correct identification of EC subtypes can be useful since renal tubular epithelial cells (RTECs) are clinically relevant. We investigate the urinary ECs report and the judgement of its clinical importance by Brazilian laboratories.</p><p><strong>Materials and methods: </strong>A survey with four questions was made available to participants of the Urinalysis External Quality Assessment Program (EQAP) from Controllab. Laboratories composed 3 groups: (1) differentiating ECs subtypes: \"squamous\", \"transitional\" and \"RTECs\"; (2) differentiating ECs subtypes: \"squamous\" or \"non-squamous\" cells; (3) without ECs subtype identification. Participants did not necessarily answer to all questions and the answers were evaluated both within the same laboratory's category and within different categories of laboratories.</p><p><strong>Results: </strong>A total of 1336 (94%) laboratories answered the survey; Group 1, 119/140 (85%) reported that ECs differentiation is important to the physician and 62% want to be evaluated by EQAP, while in Group 3, 455/1110 (41%) reported it is useful to them, however only 25% want be evaluated by EQAP. Group 2 laboratories 37/51 (73%) reported that the information is important, but only 13/52 (25%) are interested in an EQAP with differentiation of the 3 ECs subtypes.</p><p><strong>Conclusion: </strong>Most of the laboratories do not differentiate ECs in the three subtypes, despite the clinical importance of RTECs. Education of laboratory staff about the clinical significance of urinary particles should be considered a key priority.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020711"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39242074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy. 缺失的斜率:矛盾缩短激活部分凝血活酶时间的病人在非分割肝素治疗。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 DOI: 10.11613/BM.2021.021003
Ivana Lapić, Ana Lončar Vrančić, Désirée Coen Herak, Dunja Rogić

This case report describes false shortening of activated partial thromboplastin time (aPTT) due to erroneous optical reading of the clotting point in the presence of unfractionated heparin (UFH), and a biphasic waveform. Activated partial thromboplastin time performed on a coagulometer with photo-optical detection yielded an ambiguous clotting curve characterized by an early and steady decrease in light transmittance throughout the whole measuring range, with the clotting point read at 65 seconds. Further investigations included measurement of aPTT by means of a mechanical clot detection method as well as determination of another heparin-sensitive coagulation assay, that is thrombin time (TT), both being unmeasurably prolonged (> 150 seconds). Communication with clinicians revealed that the patient was on continuous UFH therapy and had an underlying sepsis, with highly elevated C-reactive protein (289 mg/L). The aPTT measurements requested at three timepoints later during the same day revealed gradual aPTT shortening and unveiled a peculiar biphasic waveform pattern. In this case, unmeasurably prolonged aPTT due to UFH therapy was masked by a biphasic aPTT curve pattern making only the first slope of the biphasic waveform visible within the measuring range. The early decrease in plasma light transmittance mimicked optical changes related to clot formation, thus causing erroneous optical reading and yielding a falsely shortened aPTT. This case emphasizes that such a pattern should be carefully inspected, especially when a combination of a critically ill condition and UFH therapy is present, in order to prevent erroneous reporting of aPTT and potential adverse effects on patient care.

本病例报告描述了由于在未分离肝素(UFH)存在的凝点的错误光学读数和双相波形而导致的活化部分凝血活素时间(aPTT)的虚假缩短。在光光学检测的凝血仪上进行的活化部分凝血活素时间产生了一个模糊的凝血曲线,其特征是在整个测量范围内透光率早期稳定下降,凝血点读数为65秒。进一步的研究包括通过机械凝块检测方法测量aPTT,以及测定另一种肝素敏感凝血试验,即凝血酶时间(TT),两者都不可测量地延长(> 150秒)。与临床医生的沟通显示,患者持续接受UFH治疗,并有潜在的败血症,c反应蛋白高度升高(289 mg/L)。在同一天晚些时候的三个时间点进行的aPTT测量显示aPTT逐渐缩短,并揭示了一种特殊的双相波形模式。在这种情况下,由于UFH治疗导致的无法测量的延长aPTT被双相aPTT曲线模式所掩盖,使得在测量范围内仅可见双相波形的第一个斜率。等离子体透光率的早期下降模拟了与凝块形成有关的光学变化,从而导致错误的光学读数并产生错误的缩短aPTT。该病例强调,应仔细检查这种模式,特别是当危重疾病和UFH治疗同时存在时,以防止aPTT的错误报告和对患者护理的潜在不良影响。
{"title":"The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy.","authors":"Ivana Lapić,&nbsp;Ana Lončar Vrančić,&nbsp;Désirée Coen Herak,&nbsp;Dunja Rogić","doi":"10.11613/BM.2021.021003","DOIUrl":"https://doi.org/10.11613/BM.2021.021003","url":null,"abstract":"<p><p>This case report describes false shortening of activated partial thromboplastin time (aPTT) due to erroneous optical reading of the clotting point in the presence of unfractionated heparin (UFH), and a biphasic waveform. Activated partial thromboplastin time performed on a coagulometer with photo-optical detection yielded an ambiguous clotting curve characterized by an early and steady decrease in light transmittance throughout the whole measuring range, with the clotting point read at 65 seconds. Further investigations included measurement of aPTT by means of a mechanical clot detection method as well as determination of another heparin-sensitive coagulation assay, that is thrombin time (TT), both being unmeasurably prolonged (> 150 seconds). Communication with clinicians revealed that the patient was on continuous UFH therapy and had an underlying sepsis, with highly elevated C-reactive protein (289 mg/L). The aPTT measurements requested at three timepoints later during the same day revealed gradual aPTT shortening and unveiled a peculiar biphasic waveform pattern. In this case, unmeasurably prolonged aPTT due to UFH therapy was masked by a biphasic aPTT curve pattern making only the first slope of the biphasic waveform visible within the measuring range. The early decrease in plasma light transmittance mimicked optical changes related to clot formation, thus causing erroneous optical reading and yielding a falsely shortened aPTT. This case emphasizes that such a pattern should be carefully inspected, especially when a combination of a critically ill condition and UFH therapy is present, in order to prevent erroneous reporting of aPTT and potential adverse effects on patient care.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"021003"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39242077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations for the application and follow-up of quality controls in medical laboratories. 对医学实验室质量控制的应用及跟踪的建议。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.020501
Jean-Marc Giannoli, Stéphanie Albarede, Thierry Avellan, Jean-Pierre Bouilloux, Régine Cartier, Richard Cohen, Nathalie Colard, Luc Essemilaire, Jean-Louis Galinier, Mathieu Kuentz, Mickaël Paris, Henri Portugal, Florian Scherrer, Jean-Pascal Siest, Anne Vassault, Jean-Michel Vialle

This is a translation of the paper "Recommendations for the application and follow-up of quality controls in medical biology laboratories" published in French in the journal Annales de Biologie Clinique (Recommandations pour la mise en place et le suivi des contrôles de qualité dans les laboratoires de biologie médicale. Ann Biol Clin (Paris). 2019;77:577-97.). The recommendations proposed in this document are the result of work conducted jointly by the Network of Accredited Medical Laboratories (LABAC), the French Society of Medical Biology (SFBC) and the Federation of Associations for External Quality Assessment (FAEEQ). The different steps of the implementation of quality controls, based on a risk analysis, are described. The changes of reagent or internal quality control (IQC) materials batches, the action to be taken in case of non-conform IQC results, the choice of external quality assessment (EQA) scheme and interpretation of their results as well as the new issue of analyses performed on several automatic systems available in the same laboratory are discussed. Finally, the concept of measurement uncertainty, the robustness of the methods as well as the specificities of near-patient testing and rapid tests are described. These recommendations cannot apply for all cases we can find in medical laboratories. The implementation of an objective alternative strategy, supported with documented evidence, might be equally considered.

本文是法语版《医学生物学实验室质量控制的应用和后续建议》的翻译,发表在《临床生物学年鉴》(Recommendations pour la mise en place et le suivi des contrôles de qualit dans les laboratoires de Biologie m dicale》杂志上。Ann Biol诊所(巴黎)。2019; 77:577 - 97)。本文件中提出的建议是由认可医学实验室网络(LABAC)、法国医学生物学学会(SFBC)和外部质量评估协会联合会(FAEEQ)共同开展的工作的结果。基于风险分析,描述了实施质量控制的不同步骤。讨论了试剂或内部质量控制(IQC)材料批次的变化,IQC结果不符合时应采取的措施,外部质量评估(EQA)方案的选择及其结果的解释,以及在同一实验室可用的多个自动系统上进行分析的新问题。最后,介绍了测量不确定度的概念、方法的鲁棒性以及近病人检测和快速检测的特殊性。这些建议并不适用于我们在医学实验室中发现的所有病例。同样可以考虑执行一项有文件证据支持的客观替代战略。
{"title":"Recommendations for the application and follow-up of quality controls in medical laboratories.","authors":"Jean-Marc Giannoli,&nbsp;Stéphanie Albarede,&nbsp;Thierry Avellan,&nbsp;Jean-Pierre Bouilloux,&nbsp;Régine Cartier,&nbsp;Richard Cohen,&nbsp;Nathalie Colard,&nbsp;Luc Essemilaire,&nbsp;Jean-Louis Galinier,&nbsp;Mathieu Kuentz,&nbsp;Mickaël Paris,&nbsp;Henri Portugal,&nbsp;Florian Scherrer,&nbsp;Jean-Pascal Siest,&nbsp;Anne Vassault,&nbsp;Jean-Michel Vialle","doi":"10.11613/BM.2021.020501","DOIUrl":"https://doi.org/10.11613/BM.2021.020501","url":null,"abstract":"<p><p>This is a translation of the paper \"Recommendations for the application and follow-up of quality controls in medical biology laboratories\" published in French in the journal Annales de Biologie Clinique (Recommandations pour la mise en place et le suivi des contrôles de qualité dans les laboratoires de biologie médicale. Ann Biol Clin (Paris). 2019;77:577-97.). The recommendations proposed in this document are the result of work conducted jointly by the Network of Accredited Medical Laboratories (LABAC), the French Society of Medical Biology (SFBC) and the Federation of Associations for External Quality Assessment (FAEEQ). The different steps of the implementation of quality controls, based on a risk analysis, are described. The changes of reagent or internal quality control (IQC) materials batches, the action to be taken in case of non-conform IQC results, the choice of external quality assessment (EQA) scheme and interpretation of their results as well as the new issue of analyses performed on several automatic systems available in the same laboratory are discussed. Finally, the concept of measurement uncertainty, the robustness of the methods as well as the specificities of near-patient testing and rapid tests are described. These recommendations cannot apply for all cases we can find in medical laboratories. The implementation of an objective alternative strategy, supported with documented evidence, might be equally considered.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020501"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38933069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. 类风湿性关节炎、系统性硬化症和系统性红斑狼疮患者透明质酸的比较。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.020701
Bogdan Cylwik, Ewa Gruszewska, Ewa Gindzienska-Sieskiewicz, Otylia Kowal-Bielecka, Lech Chrostek

Introduction: The aim of the present study was to determine and compare the concentration of hyaluronic acid (HA) in rheumatoid arthritis (RA), systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), and its correlation with parameters of disease activity and duration. The hypothesis was that HA should be increased in rheumatic diseases. We also expected that HA could be a marker of disease activity and inflammation in some of these diseases.

Materials and methods: The study group comprised 149 patients with RA, SSc and SLE hospitalized in the Department of Rheumatology and Internal Diseases, Medical University of Bialystok (Bialystok, Poland) and 30 healthy controls. The concentrations of HA, C-reactive protein (CRP) and rheumatoid factor (RF) were measured using Architect ci8200; haemoglobin, platelets on Sysmex XS-800i; and erythrocyte sedimentation rate (ESR) on Sediplus S 2000 analysers. Statistical analysis was performed using Statistica 13.3 PL.

Results: Hyaluronic acid was increased in RA, SLE and SSc when compared to controls (P < 0.001, P = 0.011, and P = 0.015, respectively). There were no differences in HA between rheumatic diseases (P = 0.840). Hyaluronic acid positively correlated with SLE activity (P = 0.025). In RA, HA positively correlated with ESR (P = 0.028) and CRP (P = 0.009). However, HA was not found to correlate with the duration of rheumatic diseases.

Conclusions: Hyaluronic acid concentration undergoes changes in rheumatic diseases with no difference between RA, SLE and SSc. In RA, HA concentration can be a marker of inflammation, while in SLE patients an indicator of disease activity.

本研究的目的是测定和比较类风湿性关节炎(RA)、系统性硬化症(SSc)和系统性红斑狼疮(SLE)患者透明质酸(HA)的浓度及其与疾病活动度和病程参数的相关性。假设是HA在风湿病中应该增加。我们还期望血凝素可以作为某些疾病的疾病活动和炎症的标志。材料和方法:研究组包括在比亚韦斯托克医科大学(波兰比亚韦斯托克)风湿病和内科住院的149例RA、SSc和SLE患者和30例健康对照。采用Architect ci8200检测血凝素(HA)、c反应蛋白(CRP)、类风湿因子(RF)浓度;Sysmex XS-800i上的血红蛋白、血小板;和红细胞沉降率(ESR)。结果:RA、SLE、SSc患者透明质酸含量较对照组明显升高(P < 0.001, P = 0.011, P = 0.015)。风湿病间HA差异无统计学意义(P = 0.840)。透明质酸与SLE活动度呈正相关(P = 0.025)。在RA中,HA与ESR (P = 0.028)和CRP (P = 0.009)呈正相关。然而,没有发现HA与风湿病病程相关。结论:风湿性疾病的透明质酸浓度发生变化,RA、SLE和SSc之间无差异。在类风湿性关节炎中,血凝素浓度可作为炎症的标志,而在SLE患者中,血凝素浓度可作为疾病活动性的指标。
{"title":"Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.","authors":"Bogdan Cylwik,&nbsp;Ewa Gruszewska,&nbsp;Ewa Gindzienska-Sieskiewicz,&nbsp;Otylia Kowal-Bielecka,&nbsp;Lech Chrostek","doi":"10.11613/BM.2021.020701","DOIUrl":"https://doi.org/10.11613/BM.2021.020701","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of the present study was to determine and compare the concentration of hyaluronic acid (HA) in rheumatoid arthritis (RA), systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), and its correlation with parameters of disease activity and duration. The hypothesis was that HA should be increased in rheumatic diseases. We also expected that HA could be a marker of disease activity and inflammation in some of these diseases.</p><p><strong>Materials and methods: </strong>The study group comprised 149 patients with RA, SSc and SLE hospitalized in the Department of Rheumatology and Internal Diseases, Medical University of Bialystok (Bialystok, Poland) and 30 healthy controls. The concentrations of HA, C-reactive protein (CRP) and rheumatoid factor (RF) were measured using Architect ci8200; haemoglobin, platelets on Sysmex XS-800i; and erythrocyte sedimentation rate (ESR) on Sediplus S 2000 analysers. Statistical analysis was performed using Statistica 13.3 PL.</p><p><strong>Results: </strong>Hyaluronic acid was increased in RA, SLE and SSc when compared to controls (P < 0.001, P = 0.011, and P = 0.015, respectively). There were no differences in HA between rheumatic diseases (P = 0.840). Hyaluronic acid positively correlated with SLE activity (P = 0.025). In RA, HA positively correlated with ESR (P = 0.028) and CRP (P = 0.009). However, HA was not found to correlate with the duration of rheumatic diseases.</p><p><strong>Conclusions: </strong>Hyaluronic acid concentration undergoes changes in rheumatic diseases with no difference between RA, SLE and SSc. In RA, HA concentration can be a marker of inflammation, while in SLE patients an indicator of disease activity.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020701"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38933071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Order of draw of blood samples affect potassium results without K-EDTA contamination during routine workflow. 在常规工作流程中,在没有K-EDTA污染的情况下,抽取血样的顺序会影响钾检测结果。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.020704
Şerif Ercan, Bahri Ramadan, Ozan Gerenli

Introduction: A specific sequence is recommended for filling blood tubes during blood collection to prevent erroneous test results due to carryover of additives. However, requirement of this procedure is still debatable. This study was aimed to investigate the potassium ethylenediaminetetraacetic acid (K-EDTA) contamination in blood samples taken after a tube containing the additive during routine workflow. The study was also carried out to examine the effect of order of draw on potassium results, regardless of K-EDTA contamination.

Materials and methods: In 388 outpatients, to determine the probability of K-EDTA cross-contamination, blood was drawn sequentially into a serum tube, followed by a tube containing K-EDTA, and by another serum tube. In another 405 outpatients, to evaluate the effect of order of draw blood unrelated to K-EDTA contamination, two serum tube were successively collected. Potassium was measured on Cobas 6000 c501 analyser (Roche Diagnostic GmbH, Mannheim, Germany) by indirect ion selective electrode method.

Results: Of paired samples collected before and after a K-EDTA tube, 24% had a potassium difference of above 0.3 mmol/L. However, no EDTA contamination was detected in these samples as well as 95% confidence intervals (CI) of limits of agreement for calcium were within the allowable error limits based on reference change values. Interestingly, of blood samples drawn successively, 24% had also a difference greater than 0.3 mmol/L for potassium.

Conclusion: Incorrect order of draw using closed blood collection system does not cause K-EDTA contamination, even in routine workflow. However, regardless of K-EDTA contamination, order of draw has significant influence on the potassium results.

简介:在采血过程中,建议使用特定的顺序填充血管,以防止由于添加剂的携带而导致错误的测试结果。然而,这一程序的要求仍有争议。本研究旨在调查在常规工作流程中,在含有添加剂的试管后采集的血液样本中的乙二胺四乙酸钾(K-EDTA)污染情况。该研究还进行了检查的顺序提取钾结果的影响,无论K-EDTA污染。材料与方法:在388例门诊患者中,为确定K-EDTA交叉污染的概率,依次将血液抽入血清管,再抽入含有K-EDTA的血清管,再抽入另一血清管。另外405例门诊患者,为评价与K-EDTA污染无关的抽血顺序的效果,先后采集了两根血清管。钾在Cobas 6000 c501分析仪(Roche Diagnostic GmbH, Mannheim, Germany)上采用间接离子选择电极法测定。结果:在K-EDTA管前后收集的成对样本中,24%的钾差异大于0.3 mmol/L。然而,在这些样品中没有检测到EDTA污染,并且钙的一致性限值的95%置信区间(CI)在基于参考变化值的允许误差范围内。有趣的是,在连续抽取的血液样本中,24%的钾含量差异也大于0.3 mmol/L。结论:闭式采血系统不正确的抽血顺序不会造成K-EDTA污染,即使在日常工作中也是如此。然而,无论K-EDTA污染与否,提取顺序对钾的结果都有显著影响。
{"title":"Order of draw of blood samples affect potassium results without K-EDTA contamination during routine workflow.","authors":"Şerif Ercan,&nbsp;Bahri Ramadan,&nbsp;Ozan Gerenli","doi":"10.11613/BM.2021.020704","DOIUrl":"https://doi.org/10.11613/BM.2021.020704","url":null,"abstract":"<p><strong>Introduction: </strong>A specific sequence is recommended for filling blood tubes during blood collection to prevent erroneous test results due to carryover of additives. However, requirement of this procedure is still debatable. This study was aimed to investigate the potassium ethylenediaminetetraacetic acid (K-EDTA) contamination in blood samples taken after a tube containing the additive during routine workflow. The study was also carried out to examine the effect of order of draw on potassium results, regardless of K-EDTA contamination.</p><p><strong>Materials and methods: </strong>In 388 outpatients, to determine the probability of K-EDTA cross-contamination, blood was drawn sequentially into a serum tube, followed by a tube containing K-EDTA, and by another serum tube. In another 405 outpatients, to evaluate the effect of order of draw blood unrelated to K-EDTA contamination, two serum tube were successively collected. Potassium was measured on Cobas 6000 c501 analyser (Roche Diagnostic GmbH, Mannheim, Germany) by indirect ion selective electrode method.</p><p><strong>Results: </strong>Of paired samples collected before and after a K-EDTA tube, 24% had a potassium difference of above 0.3 mmol/L. However, no EDTA contamination was detected in these samples as well as 95% confidence intervals (CI) of limits of agreement for calcium were within the allowable error limits based on reference change values. Interestingly, of blood samples drawn successively, 24% had also a difference greater than 0.3 mmol/L for potassium.</p><p><strong>Conclusion: </strong>Incorrect order of draw using closed blood collection system does not cause K-EDTA contamination, even in routine workflow. However, regardless of K-EDTA contamination, order of draw has significant influence on the potassium results.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020704"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047790/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38933530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Laboratory professionals' attitudes towards ISO 15189:2012 accreditation: an anonymous survey of three Croatian accredited medical laboratories. 实验室专业人员对ISO 15189:2012认证的态度:对三个克罗地亚认可的医学实验室的匿名调查。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 DOI: 10.11613/BM.2021.020712
Ivana Lapić, Dunja Rogić, Matea Ivić, Marina Tomičević, Mirjana Mariana Kardum Paro, Lovorka Đerek, Ines Alpeza Viman

Introduction: Effective implementation and continual compliance with ISO 15189:2012 require ongoing commitment and active involvement of laboratory staff. Our aim was to assess attitudes regarding accreditation implementation by conducting a survey in three Croatian accredited medical laboratories.

Materials and methods: An anonymous survey consisting of 34 questions was distributed either electronically or in a paper form a week prior to scheduled annual audits. Distributions of answers regarding age, work experience, laboratory workplace, and education level and according to the respective laboratory were compared.

Results: The overall response rate was 76% (225/297). Preference towards working in an accredited laboratory and a positive attitude were revealed by 70% and 56% participants, respectively, with better process documentation as the main advantage. Only 14% of responders considered themselves completely familiar with ISO 15189:2012. Total of 68% of responders felt that accreditation increases the usual workload, with excessive paperwork as the main contributor. Half of the responders declared partial agreement that accreditation requirements and expectations were clearly explained and claimed that their suggestions were taken into account only occasionally, which was especially emphasized by technical staff. The vast majority (89%) completely follow the prescribed protocols. Only 27% consider turnaround time monitoring useful. Competence assessment is considered efficient by 41% of responders. The majority (73%) prefer an online audit in times of COVID-19.

Conclusions: Despite an overall positive attitude towards accreditation, further efforts are needed in providing better education about ISO 15189:2012 for technical staff and modifying formats of competence assessment, in order to achieve better adherence to ISO 15189:2012 requirements.

简介:有效实施和持续符合ISO 15189:2012要求实验室工作人员的持续承诺和积极参与。我们的目的是通过在三个克罗地亚认可的医学实验室进行调查,评估对认可执行情况的态度。材料和方法:一份包含34个问题的匿名调查在预定的年度审计前一周以电子或纸质形式分发。比较了年龄、工作经验、实验室工作场所和教育程度等方面的答案分布。结果:总有效率为76%(225/297)。70%和56%的参与者分别倾向于在认可的实验室工作和积极的态度,更好的过程文件是主要优势。只有14%的应答者认为他们完全熟悉ISO 15189:2012。总共68%的应答者认为,认证增加了通常的工作量,过多的文书工作是主要贡献者。一半的答复者表示部分同意认证要求和期望得到了清楚的解释,并声称他们的建议只是偶尔得到考虑,技术人员特别强调这一点。绝大多数(89%)完全遵循规定的方案。只有27%的人认为周转时间监控是有用的。41%的应答者认为能力评估是有效的。大多数人(73%)更喜欢在COVID-19期间进行在线审计。结论:尽管对认可的总体态度是积极的,但为了更好地遵守ISO 15189:2012的要求,还需要进一步努力,为技术人员提供更好的ISO 15189:2012教育,修改能力评估的格式。
{"title":"Laboratory professionals' attitudes towards ISO 15189:2012 accreditation: an anonymous survey of three Croatian accredited medical laboratories.","authors":"Ivana Lapić,&nbsp;Dunja Rogić,&nbsp;Matea Ivić,&nbsp;Marina Tomičević,&nbsp;Mirjana Mariana Kardum Paro,&nbsp;Lovorka Đerek,&nbsp;Ines Alpeza Viman","doi":"10.11613/BM.2021.020712","DOIUrl":"https://doi.org/10.11613/BM.2021.020712","url":null,"abstract":"<p><strong>Introduction: </strong>Effective implementation and continual compliance with ISO 15189:2012 require ongoing commitment and active involvement of laboratory staff. Our aim was to assess attitudes regarding accreditation implementation by conducting a survey in three Croatian accredited medical laboratories.</p><p><strong>Materials and methods: </strong>An anonymous survey consisting of 34 questions was distributed either electronically or in a paper form a week prior to scheduled annual audits. Distributions of answers regarding age, work experience, laboratory workplace, and education level and according to the respective laboratory were compared.</p><p><strong>Results: </strong>The overall response rate was 76% (225/297). Preference towards working in an accredited laboratory and a positive attitude were revealed by 70% and 56% participants, respectively, with better process documentation as the main advantage. Only 14% of responders considered themselves completely familiar with ISO 15189:2012. Total of 68% of responders felt that accreditation increases the usual workload, with excessive paperwork as the main contributor. Half of the responders declared partial agreement that accreditation requirements and expectations were clearly explained and claimed that their suggestions were taken into account only occasionally, which was especially emphasized by technical staff. The vast majority (89%) completely follow the prescribed protocols. Only 27% consider turnaround time monitoring useful. Competence assessment is considered efficient by 41% of responders. The majority (73%) prefer an online audit in times of COVID-19.</p><p><strong>Conclusions: </strong>Despite an overall positive attitude towards accreditation, further efforts are needed in providing better education about ISO 15189:2012 for technical staff and modifying formats of competence assessment, in order to achieve better adherence to ISO 15189:2012 requirements.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020712"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39242075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample. 延迟诊断和治疗极端高甘油三酯血症由于排斥血脂样本。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.021002
Jan Van Elslande, Samira Hijjit, Katrien De Vusser, Michel Langlois, Björn Meijers, Ann Mertens, Bart Van der Schueren, Glynis Frans, Pieter Vermeersch

Introduction: Most laboratories routinely determine haemolysis, icterus and lipemia indices to identify lipemic samples and reject potentially affected results. Hypertriglyceridemia is the most common cause of lipemia and severe hypertriglyceridemia (≥ 11.3 mmol/L) is a major risk factor of acute pancreatitis.

Laboratory analysis: A 56-year-old woman attended the outpatient clinic for a follow-up visit 1 month after a kidney transplantation. Her immunosuppressive therapy consisted of corticosteroids, cyclosporine, and mycophenolic acid. The routine clinical chemistry sample was rejected due to extreme lipemia. The comment "extreme lipemic sample" was added on the report, but the requesting physician could not be reached. The Cobas 8000 gave a technical error (absorption > 3.3) for the HIL-indices (L-index: 38.6 mmol/L) which persisted after high-speed centrifugation. The patient was given a new appointment 2 days later. The new sample was also grossly lipemic and gave the same technical error (L-index: 35.9 mmol/L).

What happened: The second sample was manually diluted 20-fold after centrifugation to obtain a result for triglycerides within the measuring range (0.10-50.0 mmol/L). Triglycerides were 169.1 mmol/L, corresponding to very severe hypertriglyceridemia. This result was communicated to the nephrologist and the patient immediately recalled to the hospital. She received therapeutic plasma exchange the next day and did not develop acute pancreatitis.

Main lesson: This case illustrates the delicate balance between avoiding the release of unreliable results due to lipemia and the risk of delayed diagnosis when results are rejected. Providing an estimate of the degree of hypertriglyceridemia might be preferable to rejecting the result.

大多数实验室常规测定溶血、黄疸和血脂指数,以识别血脂样品并排除可能受影响的结果。高甘油三酯血症是脂血症最常见的原因,严重高甘油三酯血症(≥11.3 mmol/L)是急性胰腺炎的主要危险因素。实验室分析:一名56岁妇女在肾移植术后1个月到门诊随访。她的免疫抑制治疗包括皮质类固醇、环孢素和霉酚酸。常规临床化学样品因极度脂血症而被拒绝。报告中添加了“极端血脂样本”的评论,但无法联系到请求的医生。Cobas 8000对高速离心后持续存在的hil指数(L-index: 38.6 mmol/L)存在技术误差(吸收> 3.3)。2天后,病人重新预约。新样品也有严重的脂血症,并给出相同的技术误差(L指数:35.9 mmol/L)。实验过程:离心后将第二份样品手工稀释20倍,得到甘油三酯在测量范围(0.10-50.0 mmol/L)内的结果。甘油三酯169.1 mmol/L,对应非常严重的高甘油三酯血症。这一结果被告知肾病科医生,患者立即被召回医院。患者于次日接受治疗性血浆置换,未发生急性胰腺炎。主要教训:本病例说明了避免因血脂过高而发布不可靠结果与结果被拒绝时延迟诊断风险之间的微妙平衡。提供高甘油三酯血症程度的估计可能比拒绝结果更可取。
{"title":"Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample.","authors":"Jan Van Elslande,&nbsp;Samira Hijjit,&nbsp;Katrien De Vusser,&nbsp;Michel Langlois,&nbsp;Björn Meijers,&nbsp;Ann Mertens,&nbsp;Bart Van der Schueren,&nbsp;Glynis Frans,&nbsp;Pieter Vermeersch","doi":"10.11613/BM.2021.021002","DOIUrl":"https://doi.org/10.11613/BM.2021.021002","url":null,"abstract":"<p><strong>Introduction: </strong>Most laboratories routinely determine haemolysis, icterus and lipemia indices to identify lipemic samples and reject potentially affected results. Hypertriglyceridemia is the most common cause of lipemia and severe hypertriglyceridemia (≥ 11.3 mmol/L) is a major risk factor of acute pancreatitis.</p><p><strong>Laboratory analysis: </strong>A 56-year-old woman attended the outpatient clinic for a follow-up visit 1 month after a kidney transplantation. Her immunosuppressive therapy consisted of corticosteroids, cyclosporine, and mycophenolic acid. The routine clinical chemistry sample was rejected due to extreme lipemia. The comment \"extreme lipemic sample\" was added on the report, but the requesting physician could not be reached. The Cobas 8000 gave a technical error (absorption > 3.3) for the HIL-indices (L-index: 38.6 mmol/L) which persisted after high-speed centrifugation. The patient was given a new appointment 2 days later. The new sample was also grossly lipemic and gave the same technical error (L-index: 35.9 mmol/L).</p><p><strong>What happened: </strong>The second sample was manually diluted 20-fold after centrifugation to obtain a result for triglycerides within the measuring range (0.10-50.0 mmol/L). Triglycerides were 169.1 mmol/L, corresponding to very severe hypertriglyceridemia. This result was communicated to the nephrologist and the patient immediately recalled to the hospital. She received therapeutic plasma exchange the next day and did not develop acute pancreatitis.</p><p><strong>Main lesson: </strong>This case illustrates the delicate balance between avoiding the release of unreliable results due to lipemia and the risk of delayed diagnosis when results are rejected. Providing an estimate of the degree of hypertriglyceridemia might be preferable to rejecting the result.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"021002"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38932966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Decision support system through automatic algorithms and electronic request in diagnosis of anaemia for primary care patients. 通过自动算法和电子请求的决策支持系统对初级保健患者进行贫血诊断。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.020702
Enrique Rodriguez-Borja, Adela Pozo-Giraldez, Macarena Díaz-Gimenez, Ausias Hervas-Romero, Africa Corchon-Peyrallo, Inmaculada Vinyals-Bellido, Arturo Carratala Calvo

Introduction: An appropriate management of anaemia laboratory tests is crucial for a correct diagnosis and treatment. A non-sequential "shotgun" approach (where every anaemia related test is ordered) causes workload and cost increases and could be potentially harmful. We have implemented a Decision Support System through our laboratory information system (LIMS) based on reflexive algorithms and automatic generation of interpretative reports specifically in diagnosis of anaemia for primary care patients.

Materials and methods: When a request contained an "Anaemia Suspicion Study" profile, more than twenty automatic reflexive rules were activated in our LIMS based upon laboratory results. These rules normally involved the addition of reflexive tests. A final report was automatically generated for each interpretation which was always reviewed for their validity by two staff pathologists. We measured the impact of this system in the ordering of most common anaemia related tests and if a proper treatment was established based on the interpretive report.

Results: From all the studies performed, only 12% were positive being "iron deficiency" and "anaemia of chronic disease" the most frequent causes, 62% and 17%, respectively. Proper treatment was established in 88% of these anaemic patients. Total iron, transferrin, ferritin, folate and vitamin B12 demand decreased substantially after implementation representing a cost reduction of 40% only for these five tests.

Conclusions: Our system has easily improved patient outcomes, advising on individual clinical cases. We have also noticeably reduced the number of over-requested tests and laboratory costs.

导读:贫血实验室检查的适当管理是正确诊断和治疗的关键。非顺序的“散弹枪”方法(将所有与贫血相关的测试都按顺序进行)会导致工作量和成本增加,并且可能有害。我们通过我们的实验室信息系统(LIMS)实现了一个决策支持系统,该系统基于反射算法和自动生成解释性报告,专门用于初级保健患者的贫血诊断。材料和方法:当一个请求包含“贫血怀疑研究”的简介时,我们的LIMS根据实验室结果激活了20多条自动反射规则。这些规则通常包括附加的反身性测试。每次解释都会自动生成一份最终报告,并由两名工作人员病理学家审查其有效性。我们测量了该系统对大多数常见贫血相关测试排序的影响,以及是否根据解释性报告建立了适当的治疗方法。结果:在所有进行的研究中,只有12%呈阳性,其中“缺铁”和“慢性病贫血”是最常见的原因,分别为62%和17%。88%的贫血患者得到了适当的治疗。实施后,对总铁、转铁蛋白、铁蛋白、叶酸和维生素B12的需求大幅下降,仅这五种检测的成本就降低了40%。结论:我们的系统很容易改善患者的治疗效果,对个别临床病例提出建议。我们还显著减少了要求过多的检测次数和实验室费用。
{"title":"Decision support system through automatic algorithms and electronic request in diagnosis of anaemia for primary care patients.","authors":"Enrique Rodriguez-Borja,&nbsp;Adela Pozo-Giraldez,&nbsp;Macarena Díaz-Gimenez,&nbsp;Ausias Hervas-Romero,&nbsp;Africa Corchon-Peyrallo,&nbsp;Inmaculada Vinyals-Bellido,&nbsp;Arturo Carratala Calvo","doi":"10.11613/BM.2021.020702","DOIUrl":"https://doi.org/10.11613/BM.2021.020702","url":null,"abstract":"<p><strong>Introduction: </strong>An appropriate management of anaemia laboratory tests is crucial for a correct diagnosis and treatment. A non-sequential \"shotgun\" approach (where every anaemia related test is ordered) causes workload and cost increases and could be potentially harmful. We have implemented a Decision Support System through our laboratory information system (LIMS) based on reflexive algorithms and automatic generation of interpretative reports specifically in diagnosis of anaemia for primary care patients.</p><p><strong>Materials and methods: </strong>When a request contained an \"Anaemia Suspicion Study\" profile, more than twenty automatic reflexive rules were activated in our LIMS based upon laboratory results. These rules normally involved the addition of reflexive tests. A final report was automatically generated for each interpretation which was always reviewed for their validity by two staff pathologists. We measured the impact of this system in the ordering of most common anaemia related tests and if a proper treatment was established based on the interpretive report.</p><p><strong>Results: </strong>From all the studies performed, only 12% were positive being \"iron deficiency\" and \"anaemia of chronic disease\" the most frequent causes, 62% and 17%, respectively. Proper treatment was established in 88% of these anaemic patients. Total iron, transferrin, ferritin, folate and vitamin B12 demand decreased substantially after implementation representing a cost reduction of 40% only for these five tests.</p><p><strong>Conclusions: </strong>Our system has easily improved patient outcomes, advising on individual clinical cases. We have also noticeably reduced the number of over-requested tests and laboratory costs.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020702"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38933072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia. 克罗地亚 COVID-19 最初和第二波大流行期间萨格勒布儿童医院儿童感染 SARS-CoV-2 的血清流行率。
IF 3.8 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.020706
Jasna Lenicek Krleza, Renata Zrinski Topic, Vladimir Stevanovic, Amarela Lukic-Grlic, Irena Tabain, Zrinjka Misak, Goran Roic, Bernard Kaic, Dijana Mayer, Zeljka Hruskar, Ljubo Barbic, Tatjana Vilibic-Cavlek

Introduction: The study aimed to investigate the prevalence and titres of anti-SARS-CoV-2 antibodies in children treated at the Children's Hospital Zagreb in the first and the second wave of the COVID-19 pandemic. Statistical significance of difference at two time points was done to determine how restrictive epidemiological measures and exposure of children to COVID-19 infection affect this prevalence in different age groups.

Materials and methods: At the first time point (13th to 29th May 2020), 240 samples and in second time point (24th October to 23rd November 2020), 308 serum samples were tested for anti-SARS-CoV-2 antibodies by enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence immunoassay (ECLIA). Confirmation of results and titre determination was done using virus micro-neutralization test. Subjects were divided according to gender, age and epidemiological history.

Results: Seroprevalence of anti-SARS-CoV-2 antibodies differs significantly in two time points (P = 0.010). In first time point 2.9% of seropositive children were determined and in second time point 8.4%. Statistically significant difference (P = 0.007) of seroprevalence between two time points was found only in a group of children aged 11-19 years. At the first time point, all seropositive children were asymptomatic with titre < 8. At the second time point, 69.2% seropositive children were asymptomatic with titre ≥ 8.

Conclusions: The prevalence of anti-SARS-CoV-2 antibodies was significantly lower at the first time point than at the second time point. Values of virus micro-neutralization test showed that low titre in asymptomatic children was not protective at the first time point but in second time point all seropositive children had protective titre of anti-SARS-CoV-2 antibodies.

简介该研究旨在调查第一波和第二波COVID-19大流行期间在萨格勒布儿童医院接受治疗的儿童中抗SARS-CoV-2抗体的流行率和滴度。对两个时间点的差异进行统计,以确定限制性流行病学措施和儿童接触 COVID-19 感染会如何影响不同年龄组的这一流行率:在第一个时间点(2020年5月13日至29日),240份样本;在第二个时间点(2020年10月24日至11月23日),308份血清样本通过酶联免疫吸附试验(ELISA)和电化学发光免疫试验(ECLIA)检测抗SARS-CoV-2抗体。结果确认和滴度测定采用病毒微量中和试验进行。受试者根据性别、年龄和流行病学史进行分类:结果:抗 SARS-CoV-2 抗体的血清流行率在两个时间点有显著差异(P = 0.010)。第一个时间点为 2.9%,第二个时间点为 8.4%。只有在 11-19 岁的儿童群体中,两个时间点之间的血清阳性率有明显的统计学差异(P = 0.007)。在第一个时间点,所有血清反应呈阳性的儿童均无症状,滴度小于 8。在第二个时间点,69.2%的血清阳性儿童无症状,滴度≥8:抗 SARS-CoV-2 抗体的流行率在第一时间点明显低于第二时间点。病毒微量中和试验结果表明,无症状儿童的低滴度抗体在第一时间点没有保护作用,但在第二时间点,所有血清阳性儿童的抗 SARS-CoV-2 抗体滴度都具有保护作用。
{"title":"Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia.","authors":"Jasna Lenicek Krleza, Renata Zrinski Topic, Vladimir Stevanovic, Amarela Lukic-Grlic, Irena Tabain, Zrinjka Misak, Goran Roic, Bernard Kaic, Dijana Mayer, Zeljka Hruskar, Ljubo Barbic, Tatjana Vilibic-Cavlek","doi":"10.11613/BM.2021.020706","DOIUrl":"10.11613/BM.2021.020706","url":null,"abstract":"<p><strong>Introduction: </strong>The study aimed to investigate the prevalence and titres of anti-SARS-CoV-2 antibodies in children treated at the Children's Hospital Zagreb in the first and the second wave of the COVID-19 pandemic. Statistical significance of difference at two time points was done to determine how restrictive epidemiological measures and exposure of children to COVID-19 infection affect this prevalence in different age groups.</p><p><strong>Materials and methods: </strong>At the first time point (13th to 29th May 2020), 240 samples and in second time point (24th October to 23rd November 2020), 308 serum samples were tested for anti-SARS-CoV-2 antibodies by enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence immunoassay (ECLIA). Confirmation of results and titre determination was done using virus micro-neutralization test. Subjects were divided according to gender, age and epidemiological history.</p><p><strong>Results: </strong>Seroprevalence of anti-SARS-CoV-2 antibodies differs significantly in two time points (P = 0.010). In first time point 2.9% of seropositive children were determined and in second time point 8.4%. Statistically significant difference (P = 0.007) of seroprevalence between two time points was found only in a group of children aged 11-19 years. At the first time point, all seropositive children were asymptomatic with titre < 8. At the second time point, 69.2% seropositive children were asymptomatic with titre ≥ 8.</p><p><strong>Conclusions: </strong>The prevalence of anti-SARS-CoV-2 antibodies was significantly lower at the first time point than at the second time point. Values of virus micro-neutralization test showed that low titre in asymptomatic children was not protective at the first time point but in second time point all seropositive children had protective titre of anti-SARS-CoV-2 antibodies.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020706"},"PeriodicalIF":3.8,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38933532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of single comments left for bioRxiv preprints till September 2019. 截至2019年9月的bioRxiv预印本单评论分析。
IF 3.3 3区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2021-06-15 Epub Date: 2021-04-15 DOI: 10.11613/BM.2021.020201
Mario Malički, Joseph Costello, Juan Pablo Alperin, Lauren A Maggio

Introduction: While early commenting on studies is seen as one of the advantages of preprints, the type of such comments, and the people who post them, have not been systematically explored.

Materials and methods: We analysed comments posted between 21 May 2015 and 9 September 2019 for 1983 bioRxiv preprints that received only one comment on the bioRxiv website. The comment types were classified by three coders independently, with all differences resolved by consensus.

Results: Our analysis showed that 69% of comments were posted by non-authors (N = 1366), and 31% by the preprints' authors themselves (N = 617). Twelve percent of non-author comments (N = 168) were full review reports traditionally found during journal review, while the rest most commonly contained praises (N = 577, 42%), suggestions (N = 399, 29%), or criticisms (N = 226, 17%). Authors' comments most commonly contained publication status updates (N = 354, 57%), additional study information (N = 158, 26%), or solicited feedback for the preprints (N = 65, 11%).

Conclusions: Our results indicate that comments posted for bioRxiv preprints may have potential benefits for both the public and the scholarly community. Further research is needed to measure the direct impact of these comments on comments made by journal peer reviewers, subsequent preprint versions or journal publications.

虽然对研究的早期评论被视为预印本的优势之一,但此类评论的类型以及发布这些评论的人尚未被系统地探索过。材料和方法:我们分析了在2015年5月21日至2019年9月9日期间发布的关于1983年bioRxiv预印本的评论,这些评论在bioRxiv网站上只收到一条评论。注释类型由三个编码员独立分类,所有差异通过共识解决。结果:我们的分析显示,69%的评论是由非作者发表的(N = 1366), 31%是由预印本作者本人发表的(N = 617)。12%的非作者评论(N = 168)是传统上在期刊评审中发现的完整评论报告,而其余的最常见的是赞扬(N = 577,42%),建议(N = 399, 29%)或批评(N = 226,17%)。作者评论最常见的内容包括发表状态更新(N = 354,57%)、附加研究信息(N = 158, 26%)或预印本征求反馈(N = 65, 11%)。结论:我们的研究结果表明,对bioRxiv预印本发表的评论可能对公众和学术界都有潜在的好处。需要进一步的研究来衡量这些评论对期刊同行审稿人的评论、随后的预印本版本或期刊出版物的直接影响。
{"title":"Analysis of single comments left for bioRxiv preprints till September 2019.","authors":"Mario Malički, Joseph Costello, Juan Pablo Alperin, Lauren A Maggio","doi":"10.11613/BM.2021.020201","DOIUrl":"10.11613/BM.2021.020201","url":null,"abstract":"<p><strong>Introduction: </strong>While early commenting on studies is seen as one of the advantages of preprints, the type of such comments, and the people who post them, have not been systematically explored.</p><p><strong>Materials and methods: </strong>We analysed comments posted between 21 May 2015 and 9 September 2019 for 1983 bioRxiv preprints that received only one comment on the bioRxiv website. The comment types were classified by three coders independently, with all differences resolved by consensus.</p><p><strong>Results: </strong>Our analysis showed that 69% of comments were posted by non-authors (N = 1366), and 31% by the preprints' authors themselves (N = 617). Twelve percent of non-author comments (N = 168) were full review reports traditionally found during journal review, while the rest most commonly contained praises (N = 577, 42%), suggestions (N = 399, 29%), or criticisms (N = 226, 17%). Authors' comments most commonly contained publication status updates (N = 354, 57%), additional study information (N = 158, 26%), or solicited feedback for the preprints (N = 65, 11%).</p><p><strong>Conclusions: </strong>Our results indicate that comments posted for bioRxiv preprints may have potential benefits for both the public and the scholarly community. Further research is needed to measure the direct impact of these comments on comments made by journal peer reviewers, subsequent preprint versions or journal publications.</p>","PeriodicalId":9021,"journal":{"name":"Biochemia Medica","volume":"31 2","pages":"020201"},"PeriodicalIF":3.3,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38941633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Biochemia Medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1